Abstract:Background: Glucose regulated protein 78 (GRP78) is a resident chaperone of the endoplasmic reticulum and a master regulator of the unfolded protein response under physiological and pathological cell stress conditions. GRP78 is overexpressed in many cancers, regulating a variety of signaling pathways associated with tumor initiation, proliferation, adhesion and invasion which contributes to metastatic spread. GRP78 can also regulate cell survival and apoptotic pathways to alter responsiveness to anticancer drugs. Tumors that reside in or metastasize to the bone and bone marrow (BM) space can develop pro-survival signals through their direct adhesive interactions with stromal elements of this niche thereby resisting the cytotoxic effects of drug treatment. In this study, we report a direct correlation between GRP78 and the adhesion molecule N-cadherin (N-cad), known to play a critical role in the adhesive interactions of multiple myeloma and metastatic prostate cancer with the bone microenvironment. Methods: N-cad expression levels (transcription and protein) were evaluated upon siRNA mediated silencing of GRP78 in the MM.1S multiple myeloma and the PC3 metastatic prostate cancer cell lines. Furthermore, we evaluated the effects of GRP78 knockdown (KD) on epithelial-mesenchymal (EMT) transition markers, morphological changes and adhesion of PC3 cells. Results: GRP78 KD led to concomitant downregulation of N-cad in both tumors types. In PC3 cells, GRP78 KD significantly decreased E-cadherin (E-cad) expression likely associated with the induction in TGF-β1 expression. Furthermore, GRP78 KD also triggered drastic changes in PC3 cells morphology and decreased their adhesion to osteoblasts (OSB) dependent, in part, to the reduced N-cad expression. Conclusion: This work implicates GRP78 as a modulator of cell adhesion markers in MM and PCa. Our results may have clinical implications underscoring GRP78 as a potential therapeutic target to reduce the adhesive nature of metastatic tumors to the bone niche.

Glucose-regulated protein 78 modulates cell growth, epithelial–mesenchymal transition, and oxidative stress in the hyperplastic prostate

Hypoxia-induced Autophagy Promotes Human Prostate Stromal Cells Survival and ER-stress

High glucose promotes benign prostatic hyperplasia by downregulating PDK4 expression

Overexpression of Glucose-Regulated Protein 78 in Colon Cancer.

GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate

Targeting the GRP78 Pathway for Cancer Therapy

Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells

Roles of GRP78 in physiology and cancer

Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review

Recent Advances in Small Molecule and Peptide Inhibitors of Glucose-Regulated Protein 78 for Cancer Therapy

S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate

Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (CXCL13) in Hyperplastic Prostate

Expression of glucose-regulated protein 78 as prognostic biomarkers for triple-negative breast cancer

GRP78 targeting: Hitting two birds with a stone

The Interaction Between MSX1 and GRP78 Promotes the Proliferation of Prostate Cancer Cell PC-3

A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance

Inhibition of GLS Suppresses Proliferation and Promotes Apoptosis in Prostate Cancer

GRP78 at the Centre of the Stage in Cancer and Neuroprotection

Identification Of Key Genes And Pathways In Benign Prostatic Hyperplasia